Logo for Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Investor Relations Material

Latest events

Logo for Jacobio Pharmaceuticals Group

H2 2024

24 Apr, 2025
Logo for Jacobio Pharmaceuticals Group

H1 2024

27 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Jacobio Pharmaceuticals Group Co., Ltd.

Access all reports
Jacobio Pharmaceuticals Group Co., Ltd. is a Chinese biopharmaceutical company focused on innovative drug discovery and development. It concentrates on oncology and immunology, advancing a pipeline of targeted therapies and immune-oncology treatments. The company uses in-house research platforms and conducts clinical trials both domestically and internationally. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.